Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Novartis' big PD-1 bet turns sour; $350M resurrection story; Contraceptive for men heads to clinic; and more
3 years ago
Weekly
US government orders 2.5M more monkeypox vaccine doses from Bavarian Nordic via CMO
3 years ago
Pharma
Manufacturing
Merck KGaA kicks off startup collaboration program in Asia
3 years ago
Pharma
Pfizer celebrates a new FDA approval as the Xalkori franchise slowly winds down
3 years ago
Pharma
FDA+
J&J objects to Sanofi’s '#1 Doctor Recommended' claims about heartburn drug Zantac
3 years ago
Pharma
Marketing
Illumina strikes $325M deal to end years-long patent battles
3 years ago
Pharma
Law
Pfizer's Hospira issues a recall for a batch of propofol due to a visible particulate
3 years ago
Pharma
FDA+
FDA user fee bill deadline falls apart? Thousands of pink slips for FDA could be coming as Burr seeks to start anew
3 years ago
FDA+
Law
Canadian CRO Altasciences kicks off client manufacturing expansion in Philadelphia
3 years ago
Manufacturing
Kyowa Kirin pulls the plug on drug development for successor to Parkinson's drug Nourianz
3 years ago
R&D
As the consumer group splits away today, what will New GSK buy now?
3 years ago
Bioregnum
Pharma
As Big Pharma loses interest in new antibiotics, infections are only growing stronger
3 years ago
R&D
Exclusive: After Covid pivot, biotech nabs funds to be first in the clinic with a non-hormonal contraceptive for men
3 years ago
Financing
Startups
After initial commercial foray, China's CStone mulls sale — report
3 years ago
Deals
Pfizer sues Amgen in effort to invalidate top cancer drug patent
3 years ago
Pharma
Law
Manchin plays spoiler again, but drug pricing reforms remain on the table
3 years ago
Pharma
Law
Former Spark exec to lead a gene therapy upstart of his own; Big Pharma marketing vet named CEO of Swiss biotech
3 years ago
Peer Review
Drug shortages remain low in 2021 as FDA's prevention efforts grow, report to Congress says
3 years ago
Pharma
FDA+
Cancer Moonshot moves forward with new 'Cancer Cabinet' and goals to reduce cancer
3 years ago
People
Pharma
Bayer sells testosterone treatment to German company for $500M
3 years ago
Deals
Pharma
Happify rebrands as Twill, weaving a new name for its expanded digital health and pharma business
3 years ago
Pharma
Marketing
#BIO22: Decentralized trials
3 years ago
Pharma hiring continues to grow in the US and talent competition remains tight — report
3 years ago
People
Pharma
Otsuka sponsors Ken Burns' PBS youth and mental illness documentary to drive awareness and dispel stigma
3 years ago
Pharma
Marketing
First page
Previous page
492
493
494
495
496
497
498
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit